Visteon Corporation first quarter 2011 net profit was $39m, or $0.75 per share, on product sales of $1.97bn, compared with net income of $233m on product sales of $1.85bn for the first quarter of 2010. But last year's result included a $237m net gain related to the termination of company-paid medical, prescription drug and life insurance coverage benefits under US post-retirement employee benefit (OPEB) plans. Adjusted EBITDA for Q1 2011 was $159m, compared with $161m in first quarter 2010.